Basant Maheshwari has revealed the names of the stocks that he is bullish on and explained the strategies that he will adopt in 2019 to rake in multibagger gains for himself and his PMS clients
Subscribe to Blog via Email
Join 474 other subscribers
- Mphasis is at an inflection point. It is taking giant strides to capture the early-mover advantageMphasis is at an inflection point. It is taking giant strides to capture the early-mover advantage in Gen-AI. Gen-AI shall change the way IT Services cos do business. It is also a perfect proxy for playing the interest rate cut cycle in the US along with recovery in the BFS segment https://rakesh-jhunjhunwala.in/mpha...y-for-target-price-of-₹3500-17-upside-nuvama/... Mphasis is at […]
- F&O trader Mitesh Patel recently bought a Porshe Cayenne costing ₹1.5 CrMany astute F&O traders are making tons of money. Noted trader Mitesh Patel announced recently that he has bought a Porshe Cayenne. "Earlier a luxury car is meant only for celebrities & business persons only. Now a trader and investor can also do wonder. A journey from Volkswagen Polo ( 2017 ) to Volkswagen Tiguan […]
- Saurabh Mukherjea has added 3 stocks to the Marcellus Rising Giants PMS portfolioChanges to the Rising Giants PMS portfolio (as of July 31, 2024) Addition of CMS Info Systems Limited: CMS is a business services company with leadership in cash management market, a growing presence in ATM managed services market, and now expanding into tech solutions (remote monitoring and software). On back of its scale and a […]
Recent Posts
- Mphasis is taking giant strides to capture the early-mover advantage in Gen-AI domain. Buy for target price of ₹3500 (17% upside): Nuvama
- Awfis Space Solutions is seeing favorable market dynamics, flex seat demand to grow at 23.3% CAGR over 2023-26E. Buy for target price of ₹1013 (35% upside): Nuvama
- Pharma is back on the growth track with robust revenue, higher profitability & cost optimization. Top 3 Pharma stocks to buy by Axis Securities
- Aditya Birla Capital Ltd is a financial conglomerate well poised for accelerated growth!!! Buy for target price of ₹280 (26.2% upside): SBI Securities
- Nifty 12 month target using FY25E EPS & PE of 22x is 27,500. Use dips to build a long-term portfolio of quality stocks: ICICI Direct
Recent Comments